Antiphospholipid antibodies and risk for recurrent vascular events [2] (multiple letters)

JAMA

Volumn 291, Issue 22, 2004, Pages 2701-2703

  Cabral, Antonio R ^a   Ruiz Irastorza, Guillermo ^b   Khamashta, Munther A ^c   Hughes, Graham R V ^c   Wahl, Denis ^d   Regnault, Véronique ^e   De Moerloose, Philippe ^f   Lecompte, Thomas ^d   Levine, Steven R ^g   Brey, Robin L ^g   Tilley, Barbara C ^g   Triplett, Douglas A ^g   Thompson, J L P ^g   Sacco, Ralph L ^g   Mohr, J P ^g  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; WARFARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; DIAGNOSTIC ACCURACY; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; STROKE; THROMBOSIS; BLOOD; CEREBROVASCULAR ACCIDENT; IMMUNOLOGY; NOTE; RISK FACTOR; INTERNATIONAL NORMALIZED RATIO;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; CEREBROVASCULAR ACCIDENT; HUMANS; RISK FACTORS; THROMBOSIS; INTERNATIONAL NORMALIZED RATIO;

EID: 2642559706     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.22.2701-b     Document Type: Letter

References (0)